Lidocaína endovenosa domiciliaria en cuidados paliativos

  1. Villamil Cajoto, Iago 1
  2. Álvarez Pérez, Alicia 1
  3. Marcos Fernández, Mariana 1
  4. Balea Vázquez, Lucía 1
  5. Melchor Armiño, Íñigo 1
  1. 1 Hospital da Costa, Unidade de Hospitalización a Domicilio, Burela, Lugo, España
Revista:
Hospital a Domicilio

ISSN: 2530-5115

Año de publicación: 2022

Volumen: 6

Número: 1

Páginas: 47-52

Tipo: Artículo

DOI: 10.22585/HOSPDOMIC.V6I1.150 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Hospital a Domicilio

Objetivos de desarrollo sostenible

Resumen

Introduction: Neuropathic pain is a often difficult to control pain and is suitable of different therapeutic approaches. Method: Lidocaine is a local anesthesic and its endovenous use is sometimes necessary to control neuropathic pain. There is no reported use of this drug at home. Results: We performed the lidocaine endovenous infusion in two patients with neuropathic pain achieving significant clinical improvement. Conclusions: Endovenous lidocaine infusion at home, is a safe and effective proceeding for patients with neuropathic pain.

Referencias bibliográficas

  • Regan JM, Peng P. Neurophisiology cancer pain. Cancer Control. 2000;7(2):111-9.
  • Stute P, Soukup J, Menzel M, Sabatowski R, Grond S. Analysis and treatment of different types of neuropathic cancer pain. J Pain Symtom Manage. 2003;26(6):1123-31.
  • Tavares Mendonça F, Campos Reis M, Alvene Aguiar J, Calvano LA. Systemic lidocaine for perioperative analgesia: A literature review. J Anest Inten Care Med. 2015;1(1):e555551.
  • Scholz A. Mechanisms of (local) anaesthetics on voltage gated sodium and other ion channels. Br J Anaesth. 2002;89(1):52-61.
  • Tanelian DL, Brose WG: Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology. 1991;74(5):949–51.
  • Biella G, Sotgiu ML. Central effects of systemic lidocaine mediated by glycine spinal receptors: an iontophoretic study in the rat spinal cord. Brain Res. 1993;603(2):201–6.
  • Zhu B, Zhou X, Zhou Q, Wang H, Wang S, Luo K. Intra-Venous Lidocaine to Relieve Neuropathic Pain: A Systematic Review and Meta-Analysis. Front Neurol. 2019;10:954.
  • Dunn LK, Durieux ME. Perioperative use of intravenous lidocaine. Anesthesiol. 2017;126(4):729-7.
  • Carroll IR, Younger JW, Mackey SC. Pain quality predicts lidocaine analgesia among patients with suspected neuropathic pain. Pain Med. 2010;11(4):617-21.
  • Salas S, Auquier P, Duffaud F, Garnier SR, Deschamps M, Honoré S. Efficacy of lidocaine in patients receiving palliative care with opioid refractory cancer pain with a neuropathic component: study protocol for a randomized controlled study. Trials 2014;15:e318.
Fuente de los datos: Dialnet